What is the recommended dose of Vitamin K1 (phytonadione) for newborns and adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Vitamin K1 (Phytonadione) Dosing for Newborns and Adults

For newborns, a single intramuscular dose of 0.5 to 1.0 mg vitamin K1 should be administered within one hour of birth; for adults, the recommended dose ranges from 2.5 to 10 mg for most indications, with up to 25-50 mg for severe cases. 1, 2

Vitamin K1 Dosing for Newborns

  • Intramuscular (IM) administration is the preferred route for newborns due to its superior efficacy and reliability 3
  • The recommended IM dose is 0.5 to 1.0 mg administered within one hour of birth 2, 1
  • For parents who decline IM administration, oral vitamin K1 can be given using one of these regimens:
    • 3 × 2 mg orally at birth, at 4-6 days, and at 4-6 weeks 3
    • 2 mg orally at birth, followed by weekly doses of 1 mg for 3 months 3
    • Daily supplementation of 25 μg for exclusively breastfed infants following an initial 1 mg dose 4

Special Considerations for Newborns

  • The oral route is not appropriate for preterm infants, infants with cholestasis, impaired intestinal absorption, or those too unwell to take oral vitamin K1 3
  • For preterm infants on parenteral nutrition, the recommended dose is 10 μg/kg/day 2
  • If an infant vomits or regurgitates within 1 hour of oral administration, the dose should be repeated 3
  • For infants whose mothers have taken medications that interfere with vitamin K metabolism, additional monitoring and dosing may be required 3, 5

Efficacy and Safety Considerations

  • IM administration has been shown to be more effective than oral administration in preventing late vitamin K deficiency bleeding (VKDB) 4, 6
  • Preterm infants given 0.2 mg IM maintained adequate vitamin K status until a median age of 25 days without evidence of vitamin K epoxide accumulation, suggesting this lower dose may be appropriate for premature infants 7
  • Parental refusal of vitamin K prophylaxis should be documented due to the risk of late VKDB 3

Vitamin K1 Dosing for Adults

  • For correction of anticoagulant-induced prothrombin deficiency: 2.5 to 10 mg initially, with up to 25 mg in some cases 1
  • For severe cases: up to 50 mg may be required in rare instances 1
  • For hypoprothrombinemia due to other causes: 2.5 to 25 mg, with up to 50 mg rarely needed 1
  • For adults on parenteral nutrition: 200 μg/day 2

Administration Considerations for Adults

  • When administering intravenously, the injection should be given very slowly, not exceeding 1 mg per minute 1
  • The maximum effect for IV administration occurs within 6-12 hours, while oral supplementation takes about 24 hours to reach full effect 2
  • Subcutaneous administration should be preferred over IV when possible to avoid the small risk of anaphylactic reactions 1
  • For patients on anticoagulant therapy, vitamin K administration may affect response to these medications, requiring monitoring of coagulation parameters 2

Monitoring and Follow-up

  • The response to vitamin K supplementation (shortening of prothrombin time within 2-4 hours) can be diagnostic of hemorrhagic disease 1
  • For patients with ongoing anticoagulant therapy, frequency and amount of subsequent doses should be determined by prothrombin time response 1
  • In cases of shock or excessive blood loss, whole blood or component therapy may be indicated in addition to vitamin K 1

Vitamin K1 should be protected from light at all times, and parenteral preparations should be inspected for particulate matter and discoloration prior to administration 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.